Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity

Thrombosis Research

Volumn 67, Issue 5, 1992, Pages 517-531

  Rao, L Vijaya Mohan ^a   Tait, Jonathan F ^b   Hoang, An D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

anionic phospholipid; Annexin V; factor VII; prothrombinase; tissue factor

Indexed keywords

ANNEXIN; BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

ANNEXIN V; BINDING SITES; BLOOD COAGULATION; FACTOR VIIA; FEMALE; HUMAN; MULTIENZYME COMPLEXES; OVARIAN NEOPLASMS; PHOSPHATIDYLSERINES; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOPLASTIN; TUMOR CELLS, CULTURED;

EID: 0026453558     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(92)90013-Z     Document Type: Article

References (42)

1. Procoagulant activity of sarcoma sublines with different metastatic potential
2. Procoagulant activity associated with plasma membrane vesicle shed by cultured tumor cells
3. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader
4. Cooperative interaction between factor VII and cell surface expressed tissue factor
5. Tumor cell generation of thrombin via functional prothrombinase assembly
6. Tumor cells augment the factor Xa-catalyzed conversion of prothrombin to thrombin
7. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine
8. Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium
9. The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor
10. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function
11. Characterization of factor VII associated with tissue factor in solution
12. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical vein cord
13. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation
14. Human placental anticoagulant protein; Isolation and characterization
15. Structure and expression of cDNA for an inhibitor of blood coagulation from human placenta: a new lipoprotein like protein
16. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family
17. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family
18. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers
19. Binding of annexin V/placental anticoagulant protein I to platelets
20. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles
21. The role of activated human platelets in prothrombin and factor X activation
22. Changes in membrane phospholipid distribution during platelet activation
23. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets
24. Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apolipoprotein A-II
25. Purification of human factor VII utilizing O(diethylamionoethyl)-Sephadex and sulfopropyl-Sephadex chromatography
26. A simplified procedure for purification of human prothrombin, factor IX and factor X
27. Characterization of anti-tissue factor antibody and its use in immunoaffinity purification of human tissue factor
28. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: A kinetic study
29. Phospholipid vesicle formation and transmembrane protein incorporation
30. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation
31. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces
32. Protein and cell membrane iodinations with a sparingly soluble chloroamide,1,3,4,6-tetrachloro-3α,6α-diphenylglycouril
33. Binding of factors IX and IXa to cultured vascular endothelial cells
34. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
35. The functional significance of vitamin K action
36. Interaction of vitamin K-dependent proteins with membranes
37. The interaction of bovine factor IX, its activation intermediate, factor IXα, and its activation products, factor IXaα and factor IXaß with acidic phospholipid vesicles of various compositions
38. Properties of factor VIIa/tissue factor complexes in an umbilical vein model
39. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of hemostatic balance by endothelial cells
40. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein
41. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid bound substrate: Fluid phase factor X regulates the extrinsic system
42. In-vivo antithrombotic potency of placental protein 4 (annexin V)